News

AI Ethics Meets Social Impact at Blackbaud's bbcon 2026

AI Ethics Meets Social Impact at Blackbaud's bbcon 2026

You ever think about how AI might shape the future of doing good in the world? Well, Blackbaud seems to be on top of it, and they're bringing an impressive voice to the table: Priya Lakhani, OBE. She's going to grace the stage at bbcon 2026, ready to lay down what it means to marry innovation and ethics in AI for social good.

Blackbaud's AI Vision: Beyond The Sales Pitch

Now, Blackbaud (NASDAQ:BLKB) ain't just whispering sweet nothings this time. They’re getting serious with their tech conference, showcasing over 100 sessions that promise to spill some real insights for folks in non-profits, educational institutions, and more. They've managed to corral industry leaders, and sweet-talk Priya Lakhani into leading the charge with her keynote. Her talk, titled "The Art of What's Possible: Responsible AI for Social Impact," is laying out a blueprint for all those who hope to step in the ring with AI while keeping a cool moral compass.

It's not just about chucking out phrases like "responsible AI" and hoping it sticks. Nah, Lakhani’s approach is all about using AI thoughtfully—complete with ethical guardrails—whether it’s to streamline operations or drive hefty fundraising goals.

Lakhani's Take: AI with a Conscience

When Lakhani takes the main stage, she's going to dissect how AI, when paired with ethics, can be a game-changer for social impact groups. This isn't your run-of-the-mill keynote fluff. It's about leveraging AI without losing trust, which, as Todd Lant, Blackbaud’s chief customer officer points out, is more crucial now than ever.

“In a time of rapid AI innovation, trust is more important than ever."

Lakhani plans to follow up with a panel discussion, getting into the nitty-gritty of how various organizations harness AI to amp up their missions. It's practically a masterclass in what's achievable when AI technology is used right.

The Whole Enchilada at bbcon 2026

So, what's the bigger picture at this bbcon 2026 shindig? Let me tell you, it’s a buffet of learning. Besides Lakhani, there’s an eclectic mix of sessions all aimed at stirring something in attendees, whether they're physically in Columbus, Ohio, or tuning in virtually. And if that wasn't enough, the conference wraps up with a feel-good punch—Leslie Odom, Jr. is set to close the event with a fireside chat and live performance that'll probably get the heartstrings twanged a little.

Why Investors Should Keep An Eye On Blackbaud

From an investor’s viewpoint, Blackbaud's angle of tickling the social responsibility nerve with AI isn't just some benevolent gesture. If Priya Lakhani can lay down a convincing case for ethical AI steering social missions, we might see the company's reputation—and stock—get a hefty boost. It's that whole "propel impact at scale" business, where big data meets big promises, and Blackbaud is the name that keeps popping up.

While they're busy being lauded by Fast Company and Forbes for their innovative spirit and workplace environment, one can't ignore the potential potholes ahead. The forward-looking statements from Blackbaud keep a healthy tinge of "but let's not get too far ahead of ourselves." They’re up against tech changes, lingering economic shadows, and the unpredictable nature of software product success. It ain't a smooth ride to the top, but it's one to watch if you believe in AI with a moral code leading the charge.

A Lasting Impression

As the curtains fall on bbcon 2026, the bigger question sits with what ripple effects these discussions will unleash. It’s not just about looking snazzy on stage. It's about embedding responsible AI into the beating heart of companies aiming for social impact. If Blackbaud can play its cards right, it’s not just a win for them but a win for the entire sector.

So buckle up, investors and do-gooders, because this October, Blackbaud’s conference might just be the jumping-off point for AI to transform the social impact landscape, one ethical decision at a time.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Haivision Set to Unveil Q3 2026 Earnings on Sep 9

Updated Category News Views 9

Anticipation Builds for Haivision's Upcoming Earnings Call Investors better keep their ears peeled for September 9, 2026, because that's when Haivision Systems Inc. (TSX: HAI) is rolling out its financial figures for Q3. There's something electrifying about the time leading up to an earnings call, where speculation meets reality. You’ll want to pay close attention to...

Continue Reading
25 Years of Photographic Innovation: Epson Celebrates

Updated Category News Views 7

Reviving an Iconic Photography Exhibit Photography lovers, gather 'round. We're diving deep into the realm where artistry and technology collide—Epson's celebration of the 25th anniversary of the 'America in Detail' exhibition. Back at the turn of the millennium, photographer Stephen Wilkes hit the road for a 52-day shooting marathon across the United States. What he...

Continue Reading
Huey Magoo’s Lends a Hand to Reeve Foundation in Sept

Updated Category News Views 5

Chicken with a Cause: Huey Magoo's September Campaign When you think of fast food, charity doesn’t usually spring to mind. But this September, Huey Magoo's is shaking up the fast-casual scene with a philanthropic twist worthy of a double take. They're teaming up with the Christopher & Dana Reeve Foundation, and folks, it's all about turning pocket change into real...

Continue Reading
Florida Southern Rebrands Honors Program into College

Updated Category News Views 7

Transforming an honors program into a full-blown honors college isn't just a ceremonial upgrade; it's a strategic leap aiming to sculpt future leaders. Florida Southern College (FSC) in Lakeland, Florida, has embraced this leap, launching a comprehensive Honors College designed to deepen academic pursuits and foster a thriving intellectual community. The vibes are...

Continue Reading
Trinasolar Shines with Tier 1 Status Amid 2026 Cleantech Boom

Updated Category News Views 5

Trinasolar Keeps Riding the Wave of Innovation Well, they've done it again. Trinasolar is holding tight to their Tier 1 status on S&P Global's Cleantech Companies List for both PV modules and energy storage systems. This ain't just a feather in their cap; it's more like a parade banner waving high, touting their prowess in the ever-competitive field of clean energy. For...

Continue Reading
SMPL Faces Lawsuit: Investors Urged to Take Action

Updated Category News Views 7

SMPL's Tumultuous Legal Battle Unfolds A real shocker grips the Simply Good Foods Company (NASDAQ: SMPL), hitting the radar of every investor who thought they were on a smooth sail. We're looking at a full-blown securities fraud class action lawsuit filed by some frustrated shareholders, claiming the company didn't quite lay all its cards on the table regarding its OWYN...

Continue Reading
EquipmentShare Faces Legal Heat Over Fraud Allegations

Updated Category News Views 2

EquipmentShare's Legal Storm: What Went Wrong? If there's one thing that complexities in the financial road can teach you, it's that trust is fragile. EquipmentShare.com Inc. (EQPT) is in the crosshairs now, dragged into a securities fraud class action suit. You might be pondering, what cracked the surface? Allegedly, this outfit’s financials were packed tighter than a...

Continue Reading
APA.LIVE and YES, And… Forge a Fresh Event Path

Updated Category News Views 7

Innovation Takes Center Stage in Live Productions Well, this one's a bit different, folks. When it comes to corporate meetings that are supposed to shake off the dust of dread and monotony, APA.LIVE is punching above its weight class. These guys are taking a swing at traditional snooze-inducing conferences by partnering with YES, And… Creative Services. With APA.LIVE...

Continue Reading
CompSource's Double Duty: Safety Net and Lifeline to Scholars'

Updated Category News Views 15

Heart of CompSource: Compassion Transcends Policies You wouldn’t expect to witness heartwarming tales in the insurance world, but that’s exactly what's on display here. Today, CompSource Mutual Insurance Company hosted a Lunch & Learn in Tulsa, showcasing their allegiance to Kids' Chance of Oklahoma. It’s more than just handshakes and balance sheets; it's about...

Continue Reading
Dental Anxiety Management: New Approaches Explained

Updated Category News Views 12

Facing Fear: The Dental Anxiety Dilemma Dental anxiety is no small potato for a lot of folks. It's that under-the-radar struggle faced by those ranging from jittery kids on their first visit to adults still haunted by a nightmare appointment ages ago. Turns out, it’s not just about gritting your teeth and enduring—it's dealing with sweaty palms, sleepless nights, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Sarepta Therapeutics Stock Insights and Market Trends

Updated Category News Views 159

Sarepta Therapeutics Stock Movement Explained Sarepta Therapeutics Inc. (NASDAQ: SRPT) is experiencing a notable increase in its stock price with no apparent news to explain this sudden jump. Today's trading reflects the market's curiosity and anticipation around the company's upcoming presentations and research developments. Upcoming Data Presentation This week, Sarepta...

Continue Reading
Exploring the Booming Protein Hydrolysates Market Growth

Updated Category News Views 56

The Future of Protein Hydrolysates Market The global protein hydrolysates industry is on an impressive trajectory, projected to grow from a valuation of approximately US$3.8 billion to an estimated US$6.6 billion by the end of the designated timeframe. This substantial growth is indicative of a compound annual growth rate (CAGR) of 6.1%, suggesting significant...

Continue Reading
Embecta's Strategic Conference Participation: Insights Ahead

Updated Category News Views 91

Embecta's Exciting Participation in Major Finance Conference Embecta Corp. (NASDAQ: EMBC), known for its commitment to diabetes care, has announced its participation in the prestigious J.P. Morgan Global Leveraged Finance Conference. This event, taking place in Miami, represents a significant opportunity for the company to connect with key stakeholders and share its...

Continue Reading
TRG Sells Confipetrol, Enhancing Growth in Emerging Markets

Updated Category News Views 250

TRG Finalizes Important Sale of Confipetrol S.A.S. The Rohatyn Group (“TRG”), a prominent asset manager dedicated to emerging markets and real assets, has successfully completed the sale of Confipetrol S.A.S., a vital provider of maintenance engineering services. This strategic move involves a well-regarded industrial and engineering conglomerate in Mexico and...

Continue Reading
Arcus Biosciences and Gilead Sciences' New Cancer Study Results

Updated Category News Views 167

Exciting Developments in Cancer Treatment The landscape of cancer treatment continues to evolve as Arcus Biosciences Inc. (NYSE: RCUS) announced promising overall survival data from its latest research. The results, unveiled during an ongoing study, highlight the potential of their investigational drug combination. Overview of the Clinical Study This Phase 2 EDGE-Gastric...

Continue Reading